XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...

XORTX Therapeutics (XRTX) announces the launch of a new late stage program to treat gout. The new drug development program – XRx-026 – will ...

A new drug called febuxostat has been found to reduce plasma levels of uric acid more effectively in Gout than the currently used drug allopurinol. If the results of the clinical trial are ...

Find effective medications for 'Gout treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to manage Gout.

This new study not only clarifies the causes of gout but also helps scientists explore more treatment options. Existing drugs could be used to alleviate gout symptoms. The study does have its ...

XORTX Therapeutics Inc. is a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. The company is actively involved in creating ...

Kidney stones (nephrolithiasis) and gout are both common, recurrent, extremely painful conditions, especially in patients ...